Current Approaches to Tuberculosis in the United States

被引:16
作者
Gordin, Fred M. [2 ,3 ]
Masur, Henry [1 ]
机构
[1] Natl Inst Hlth Clin Ctr, Dept Crit Care Med, Bethesda, MD 20892 USA
[2] Vet Affairs Med Ctr, Washington, DC 20422 USA
[3] George Washington Univ, Washington, DC USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2012年 / 308卷 / 03期
关键词
HIV-INFECTED ADULTS; LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; ANTIRETROVIRAL THERAPY; PULMONARY TUBERCULOSIS; MOXIFLOXACIN; RIFAPENTINE; OUTBREAK; TESTS; IDENTIFICATION;
D O I
10.1001/jama.2012.7505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tuberculosis is a major threat to global health, infecting a third of the world's population. In the United States, however, control of tuberculosis has been increasingly successful. Only 3.2% of the US population is estimated to have latent tuberculosis and there are only 11 000 cases annually of active disease. More than half the cases in this country occur in individuals born outside the United States. Human immunodeficiency virus coinfection is not a major factor in the United States, since only approximately 10% of cases are coinfected. Drug resistance is also uncommon in this country. Because the United States has more resources for the diagnosis, therapy, and public health control of tuberculosis than many regions of the world, and because many hospitals have more cases of clinically significant nontuberculous mycobacteria than tuberculosis, the management approaches to tuberculosis need to be quite different in this country than in other regions. The resurgence in interest in developing new tools and the investment in public health infrastructure will hopefully be sustained in the United States so that the effect of tuberculosis on the US population will continue to diminish, and these new tools and approaches can be adapted to both high and low prevalence areas to meet the global challenge. JAMA. 2012;308(3):283-289 www.jama.com
引用
收藏
页码:283 / 289
页数:7
相关论文
共 50 条
  • [31] Genotyping indicates marked heterogeneity of tuberculosis transmission in the United States, 2009-2018
    Rodriguez, Carly A.
    Li, Tenglong
    Self, Julie L.
    Jenkins, Helen E.
    Horsburgh, Charles R.
    White, Laura F.
    [J]. EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [32] The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease
    Bucsan, Allison N.
    Mehra, Smriti
    Khader, Shabaana A.
    Kaushal, Deepak
    [J]. PATHOGENS AND DISEASE, 2019, 77 (04):
  • [33] Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
    Stylianou, Elena
    Paul, Matthew J.
    Reljic, Rajko
    McShane, Helen
    [J]. EXPERT REVIEW OF VACCINES, 2019, 18 (12) : 1271 - 1284
  • [34] Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches
    Tandon, Rashmi
    Nath, Mahendra
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (06) : 549 - 570
  • [35] Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States
    Ekramnia, Mina
    Li, Yunfei
    Haddad, Maryam B.
    Marks, Suzanne M.
    Kammerer, J. Steve
    Swartwood, Nicole A.
    Cohen, Ted
    Miller, Jeffrey W.
    Horsburgh, C. Robert
    Salomon, Joshua A.
    Menzies, Nicolas A.
    [J]. EPIDEMIOLOGY, 2024, 35 (02) : 164 - 173
  • [36] Incipient and Subclinical Tuberculosis: Defining Early Disease States in the Context of Host Immune Response
    Achkar, Jacqueline M.
    Jenny-Avital, Elizabeth R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 204 : S1179 - S1186
  • [37] Current understanding of the immune response to tuberculosis in children
    Roy, Robindra Basu
    Whittaker, Elizabeth
    Kampmann, Beate
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (03) : 250 - 257
  • [38] Current development and future prospects in chemotherapy of tuberculosis
    Nuermberger, Eric L.
    Spigelman, Melvin K.
    Yew, Wing Wai
    [J]. RESPIROLOGY, 2010, 15 (05) : 764 - 778
  • [39] Tuberculosis in Older Adults in the United States, 1993-2008
    Pratt, Robert H.
    Winston, Carla A.
    Kammerer, J. Steve
    Armstrong, Lori R.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (05) : 851 - 857
  • [40] Priorities for Screening and Treatment of Latent Tuberculosis Infection in the United States
    Linas, Benjamin P.
    Wong, Angela Y.
    Freedberg, Kenneth A.
    Horsburgh, C. Robert, Jr.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (05) : 590 - 601